Literature DB >> 19210901

Allergic rhinoconjunctivitis: complementary treatments for the 21st century.

Simi Kapoor1, Leonard Bielory.   

Abstract

Even in the 21st century, some seeds of tradition remain firmly grounded regardless of the technological advancements of humankind. One such "tradition" involves using unconventional means-including mental healing, herbal formulas, and healing hand therapies such as acupuncture-to treat chronic illnesses. Although mental healing is unproven and energy therapy is not completely understood, acupuncture, herbal therapy, and sublingual immunotherapy have been described more extensively with mixed results that lack consistency and high-quality scientific data. Researchers are working to modernize these traditional therapies in the treatment of allergic disorders and using advanced technology to alter what some call "the earth's natural healing power" in hopes of developing a new, integrative form of medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19210901     DOI: 10.1007/s11882-009-0018-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  45 in total

1.  Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Authors:  Martin Penagos; Enrico Compalati; Francesco Tarantini; Rodrigo Baena-Cagnani; Jose Huerta; Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  Ann Allergy Asthma Immunol       Date:  2006-08       Impact factor: 6.347

2.  Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis.

Authors:  V S Saxena; K Venkateshwarlu; P Nadig; H C Barbhaiya; N Bhatia; D M Borkar; R S Gill; R K Jain; S K Katiyar; K V Nagendra Prasad; K M Nalinesha; K Nasiruddin; J P Rishi; J Roy Chowdhury; P S Saharia; B Thomas; D Bagchi
Journal:  Int J Clin Pharmacol Res       Date:  2004

3.  Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study.

Authors:  David I Bernstein; Cheryl K Bernstein; Chunqin Deng; Karen J Murphy; I Leonard Bernstein; Jonathan A Bernstein; Rakesh Shukla
Journal:  Ann Allergy Asthma Immunol       Date:  2002-03       Impact factor: 6.347

4.  A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis.

Authors:  Daniel K Ng; Pok-yu Chow; Shun-pei Ming; Siu-hung Hong; Sunny Lau; Debbie Tse; Wilson K Kwong; Mui-fong Wong; Wilfred H Wong; Yu-ming Fu; Ka-li Kwok; Handong Li; Jackson C Ho
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

5.  Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.

Authors:  Samuele E Burastero; Gianni Mistrello; Paolo Falagiani; Clara Paolucci; Daniela Breda; Daniela Roncarolo; Stefania Zanotta; Giorgio Monasterolo; Renato E Rossi
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

6.  Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.

Authors:  Ronald Dahl; Alexander Kapp; Giselda Colombo; Jan G R de Monchy; Sabina Rak; Waltraud Emminger; Bente Riis; Pernille M Grønager; Stephen R Durham
Journal:  J Allergy Clin Immunol       Date:  2007-12-26       Impact factor: 10.793

7.  Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy.

Authors:  J Savolainen; K Nieminen; K Laaksonen; T Laiho; L Jacobsen; R Lahesmaa; E O Terho; E Valovirta
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

8.  A case study of simultaneous recovery from multiple physical symptoms with medical qigong therapy.

Authors:  Kevin W Chen; Floyd D Turner
Journal:  J Altern Complement Med       Date:  2004-02       Impact factor: 2.579

9.  Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

Authors:  Alain Didier; Hans-Jörgen Malling; Margitta Worm; Friedrich Horak; Siegfried Jäger; Armelle Montagut; Claude André; Olivier de Beaumont; Michel Melac
Journal:  J Allergy Clin Immunol       Date:  2007-11-01       Impact factor: 10.793

10.  Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.

Authors:  Y Nuhoglu; S S Ozumut; C Ozdemir; M Ozdemir; C Nuhoglu; M Erguven
Journal:  J Investig Allergol Clin Immunol       Date:  2007       Impact factor: 4.333

View more
  2 in total

Review 1.  Rhinitis in the Elderly.

Authors:  Alan P Baptist; Sharmilee Nyenhuis
Journal:  Immunol Allergy Clin North Am       Date:  2016-03-04       Impact factor: 3.479

2.  The use of complementary and alternative medicine by adults with allergies: a Czech national representative survey.

Authors:  Jitka Pokladnikova; A-La Park; Jan Draessler; Anna Lukacisinova; Irena Krcmova
Journal:  BMC Complement Med Ther       Date:  2021-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.